• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Mark Zitter, MBA, Discusses Oncology Pathways

Article

Mark Zitter, MBA, CEO of the Zitter Group, states that oncology pathways can standardize the way care is delivered while improving quality and reducing costs.

Mark Zitter, MBA, CEO of the Zitter Group, states that oncology pathways can standardize the way care is delivered while improving quality and reducing costs. However, Zitter says that over the next year or so, pathways will not be the dominant factor in oncology management.

Related Videos
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
Antonio Urbina, MD
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Tina Bhatnagar, DO
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Antonio Urbina, MD
Ciara Zachary, PhD, MPH
Hearn Jay Cho, MD, PhD
Nicoletta Colombo, MD, PhD
Related Content
Prerna Mewawalla, MD

Redesigning Trials for Real-World Patient Complexity: A Q&A With Prerna Mewawalla, MD

December 4th 2025
Article

Prerna Mewawalla, MD, discusses innovative strategies to enhance cancer care access, reduce clinician burden, and improve clinical trial diversity in real-world settings.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

How expiring ACA subsidies could reshape coverage choices for employees and employers. | Image credit: @iQoncept-stock.adobe.com.jpeg

What ACA Subsidy Expiration Means for Coverage Costs, Employer Strategy, and ICHRAs: Q&A With Ben Light

December 2nd 2025
Article

With ACA subsidies ending in 2025, Ben Light explains how rising premiums may push individuals toward ICHRAs and reshape employer health coverage strategy.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

McKesson | Image Credit: © Bendix-stock.adobe.com

Shaping the Future of Community Oncology Through Sustainable Practices

December 1st 2025
Article

McKesson's report highlights key trends in community oncology, emphasizing patient-centered care, precision medicine, and the need for innovative clinical trials.

Read More

AJMC original research clinical

Health Outcomes of Dually Eligible Beneficiaries Under Different Medicare Payment Arrangements

December 1st 2025
Article

Within the same physician groups, 2-sided risk in Medicare Advantage (MA) was associated with higher quality and lower utilization for dually eligible beneficiaries compared with fee-for-service MA and traditional Medicare.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.